7th Dec 2007 08:00
ABCAM Plc07 December 2007 For immediate release 7 December 2007 ABCAM PLC ("Abcam" or "the Company") Annual Report and Accounts Abcam plc (AIM: ABC) announces that the Company's Annual Report and Accounts forthe year ended 30 June 2007 has been posted to shareholders and may also beviewed on, or downloaded from, the Company's website www.abcam.com. For further information please contact: Abcam + 44 (0) 1223 696000Jeff Iliffe, Chief Financial Officer Buchanan Communications + 44 (0) 20 7466 5000Mark Court / Mary-Jane Johnson Numis Securities + 44 (0) 20 7260 1000Nick Westlake Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts and aJapanese office in Tokyo. Abcam was admitted to AIM in November 2005 and tradesunder the ticker symbol ABC. The Company produces and distributes its own andthird party produced antibodies to academic and commercial users throughout theworld with product information provided and ordering available through theCompany's website, www.abcam.com. The antibodies are sold under the Abcam brandname. The Company's vision is to build the largest online antibody resource inthe world while also ensuring that the antibodies are of high quality andcommercially viable. Abcam now has an online catalogue of approximately 40,000products, most of which are antibodies, from over 200 suppliers supported byup-to-date and detailed technical data sheets, which are created by the Company.The Company currently employs 140 staff in its three operating companies. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
ABC.L